Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Molecular Cancer Research- United States

doi 10.1158/1541-7786.mcr-13-0212

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells With Aberrant Akt Activity

Clinical Cancer Research
Cancer ResearchOncology
2004English

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Correlation Between Activation of PI3K/AKT/mTOR Pathway and Prognosis of Breast Cancer in Chinese Women

PLoS ONE
Multidisciplinary
2015English

PI3K/Akt-sensitive MEK-independent Compensatory Circuit of ERK Activation in ER-positive PI3K-mutant T47D Breast Cancer Cells

Cellular Signalling
Cell Biology
2010English

Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen Through Activation of Akt/mTOR Signaling

PLoS ONE
Multidisciplinary
2013English

Dual PI3K/mTOR Inhibition in Colorectal Cancers withAPCandPIK3CAMutations

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

Activation of Autophagy During Farnesyl Pyrophosphate Synthase Inhibition Is Mediated Through PI3K/AKT/mTOR Signaling

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Inhibition of Esophageal Cancer Growth Through the Suppression of PI3K/AKT/mTOR Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy